Deep Learning-Based Internal Target Volume (ITV) Prediction Using Cone-Beam CT Images in Lung Stereotactic Body Radiotherapy.

Journal: Technology in cancer research & treatment
PMID:

Abstract

This study aims to develop a deep learning (DL)-based (Mask R-CNN) method to predict the internal target volume (ITV) in cone beam computed tomography (CBCT) images for lung stereotactic body radiotherapy (SBRT) patients and to evaluate the prediction accuracy of the model using 4DCT as ground truth. This study enrolled 78 phantom cases and 156 patient cases who received SBRT treatment. We used a novel DL model (Mask R-CNN) to identify and delineate lung tumor ITV in CBCT images. The results of the DL-based method were compared quantitatively with the ground truth (4DCT) using 4 metrics, including Dice Similarity Coefficient (DSC), Relative Volume Index (RVI), 3D Motion Range (R), and Hausdorff Surface Distance (HD). Paired -tests were used to determine the differences between the DL-based method and manual contouring. The DSC value for 4DCT versus CBCT is 0.86 ± 0.16 and for 4DCT versus CBCT is 0.83 ± 0.18, indicating a high similarity of tumor delineation in CBCT and 4DCT. The mean Accuracy Precision (mAP), R, RVI, and HD values for phantom evaluation are 0.94 ± 0.04, 1.37 ± 0.36, 0.79 ± 0.02, and 6.79 ± 0.68, respectively. For patient evaluation, the mAP, R, RVI, and HD achieved averaged values of 0.74 ± 0.23, 2.39 ± 1.59, 1.27 ± 0.47, and 17.00 ± 19.89, respectively. These results showed a good correlation between predicted ITV and manually contoured ITV. The phantom -value for RVI, R, and HD are 0.75, 0.08, 0.86, and patient -value are 0.53, 0.07, 0.28, respectively. These -values for phantom and patient showed no significant difference between the predicted ITV and physician's manual contouring. The current improved method (Mask R-CNN) yielded a good similarity between predicted ITV in CBCT and the manual contouring in 4DCT, thus indicating great potential for using CBCT for patient ITV contouring.

Authors

  • Zhen Li
    PepsiCo R&D, Valhalla, NY, United States.
  • Shujun Zhang
    Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai, China.
  • Libo Zhang
    Faculty of Metallurgical and Energy Engineering, Kunming University of Science and Technology Kunming 650093 China hyxia@kust.edu.cn zhanglibopaper@126.com.
  • Ya Li
    a State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering , Lanzhou University , Lanzhou , People's Republic of China.
  • Xiangpeng Zheng
    Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai, China.
  • Jie Fu
    David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, 90095, CA, USA.
  • Jianjian Qiu
    Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai, China.